CLLS - Cellectis S.A.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 1.38
52-Week Change 3-24.81%
S&P500 52-Week Change 318.80%
52 Week High 320.84
52 Week Low 39.50
50-Day Moving Average 313.05
200-Day Moving Average 313.34

Share Statistics

Avg Vol (3 month) 3108.38k
Avg Vol (10 day) 396.27k
Shares Outstanding 542.45M
Float 31.4M
% Held by Insiders 10.00%
% Held by Institutions 130.16%
Shares Short (Nov 15, 2019) 4290.03k
Short Ratio (Nov 15, 2019) 42.83
Short % of Float (Nov 15, 2019) 4N/A
Short % of Shares Outstanding (Nov 15, 2019) 40.68%
Shares Short (prior month Oct 15, 2019) 4231.01k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)-585.86%

Management Effectiveness

Return on Assets (ttm)-14.37%
Return on Equity (ttm)-23.48%

Income Statement

Revenue (ttm)19.62M
Revenue Per Share (ttm)0.46
Quarterly Revenue Growth (yoy)365.60%
Gross Profit (ttm)18.69M
EBITDA -109.59M
Net Income Avi to Common (ttm)-87.97M
Diluted EPS (ttm)-2.07
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)342.48M
Total Cash Per Share (mrq)8.07
Total Debt (mrq)47.46M
Total Debt/Equity (mrq)12.43
Current Ratio (mrq)7.99
Book Value Per Share (mrq)8.02

Cash Flow Statement

Operating Cash Flow (ttm)-86.86M
Levered Free Cash Flow (ttm)-83.54M